Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Scalable Fabrication of Metallopolymeric Superstructures for Highly Efficient Removal of Methylene Blue.

Zhou M, Yang T, Hu W, He X, Xie J, Wang P, Jia K, Liu X.

Nanomaterials (Basel). 2019 Jul 11;9(7). pii: E1001. doi: 10.3390/nano9071001.

2.

Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.

Ping X, Hu W, Xiong R, Zhang X, Teng Z, Ding M, Li L, Chang C, Xu K.

Vaccine. 2018 Aug 6;36(32 Pt B):4837-4845. doi: 10.1016/j.vaccine.2018.06.048. Epub 2018 Jun 28.

PMID:
29960799
3.

A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.

Hu W, Zhang H, Han Q, Li L, Chen Y, Xia N, Chen Z, Shu Y, Xu K, Sun B.

Vaccine. 2015 Jan 3;33(2):374-81. doi: 10.1016/j.vaccine.2014.11.007. Epub 2014 Nov 18.

PMID:
25448099
4.

Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.

Hu W, Chen A, Miao Y, Xia S, Ling Z, Xu K, Wang T, Xu Y, Cui J, Wu H, Hu G, Tian L, Wang L, Shu Y, Ma X, Xu B, Zhang J, Lin X, Bian C, Sun B.

Virology. 2013 Jan 20;435(2):320-8. doi: 10.1016/j.virol.2012.09.034. Epub 2012 Oct 16.

5.

Efficient induction of CD25- iTreg by co-immunization requires strongly antigenic epitopes for T cells.

Geng S, Yu Y, Kang Y, Pavlakis G, Jin H, Li J, Hu Y, Hu W, Wang S, Wang B.

BMC Immunol. 2011 May 5;12:27. doi: 10.1186/1471-2172-12-27.

6.

Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.

Sun Y, Bian C, Xu K, Hu W, Wang T, Cui J, Wu H, Ling Z, Ji Y, Lin G, Tian L, Zhou Y, Li B, Hu G, Yu N, An W, Pan R, Zhou P, Leng Q, Huang Z, Ma X, Sun B.

PLoS One. 2010 Dec 9;5(12):e14270. doi: 10.1371/journal.pone.0014270.

Supplemental Content

Loading ...
Support Center